Preliminary Investigation of a Smart Compression Therapy Prototype
NCT ID: NCT05610241
Last Updated: 2023-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2023-03-04
2023-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing Sensor-Guided Compression Therapy for Venous Leg Ulcers Healing Outcomes
NCT07268482
Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers
NCT01801891
Pressure and Temperature Sensor for Therapeutic Compression Garments
NCT03461549
The Use of NMES as a Home-based Therapy Following Total Knee Arthroplasty
NCT02343198
A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet
NCT02592655
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Compression Therapy System Prototype
Identifies legs randomized to receive the experimental intervention
Compression Therapy System Prototype
A device designed to deliver compression therapy at a pre-set level to the lower leg for legs with a circumference between 30-50 cm. The device provides compression through a series of three air bladders and is controlled by a battery-powered electronic module that controls compression levels by monitoring bladder pressure.
Coban 2 (2 Layer Compression Wrap)
Identifies the legs randomized to receive the control intervention
Standard Compression
Coban 2 represents the standard of care 2-layer compression wrap used to treat venous leg ulcers. The device consists of a comfort layer and a compression layer. A clinician applies the device to establish compression therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compression Therapy System Prototype
A device designed to deliver compression therapy at a pre-set level to the lower leg for legs with a circumference between 30-50 cm. The device provides compression through a series of three air bladders and is controlled by a battery-powered electronic module that controls compression levels by monitoring bladder pressure.
Standard Compression
Coban 2 represents the standard of care 2-layer compression wrap used to treat venous leg ulcers. The device consists of a comfort layer and a compression layer. A clinician applies the device to establish compression therapy.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Calf circumferences to be within 30 - 50 cm between the medial and lateral head of the gastrocnemius
* Able to understand the Patient Information Leaflet
* Willing and able to give informed consent
* Able to wear, don and doff the compression device without external help
* Willing and able to follow the requirements of the clinical investigation plan
* Presence of pedal pulses identified by hand-held Doppler (8 MHz)
* Ankle Brachial Pressure Index between 0.9 and 1.4
Exclusion Criteria
* Peripheral artery disease ( or ABPI \< 0.90 or \> 1.4), critical limb ischemia, or arterial ulceration
* Varicose veins, varicose eczema, or venous ulceration
* Chronic lower limb swelling, edema, lymphedema, or lipoedema
* Recent surgery within the last three months (such as abdominal, gynecological, hip or knee replacement, or lower limb) that may affect the study in the opinion of the investigator
* Recent trauma to a lower limb within the last three months
* Chronic obesity (defined as BMI index \>40 kg/m\^2)
* Diabetes mellitus
* Pregnancy
* A pulse rate of fewer than 40 beats/minute
* A sitting systolic blood pressure of \> 180 and \< 100 mmHg and/or a sitting diastolic pressure of \> 100 mmHg
* Any significant illness during the previous four (4) weeks
* Participation in any clinical study during the eight (8) weeks preceding the screening period
* Any evidence of edema or pain
* Skin diseases, including wounds on the feet or lower limbs
* Any history of heart, liver, kidney, or vascular diseases
* History of having been prescribed compression stockings for treatment of a medical condition
* Serious allergies
* Dermatitis with oozing or fragile skin
* Persons currently using NSAID, Diuretics, Vasodilators, and steriods
* Drivers and Driving Professionals
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal College of Surgeons, Ireland
OTHER
Tyndall National Institute
UNKNOWN
Enterprise Ireland
OTHER_GOV
DeRoyal Industries, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Declan Patton, PhD
Role: STUDY_DIRECTOR
RCSI University of Medicine and Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RCSI Education and Research Centre
Dublin, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CI52248
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.